Results 161 to 170 of about 22,026 (263)

Effects of coaching with data management system intervention or usual care on glycemic control in patients with type 2 diabetes: A multicentre, randomised controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 3377-3385, April 2026.
Abstract Aims Integrating a diabetes management system (DMS) and personal coaching in patient care may reduce the burden of type 2 diabetes (T2DM) on patients and help address the multifaceted challenges associated with diabetes management. This study aims to assess the impact of the DMS with online coaching in patients with T2DM on changes in HbA1c ...
Marlo Verket, Larissa F. Buitkamp, Niveditha Daneeza Dinesh Kanna, Andreas Thomas, Ralf Denger, Friedrich Petry, Oliver Schubert‐Olesen, Wolfgang Stütz, Jörg Simon, Monika Pihusch, Iris Dötsch, Gabriela Krob, Dietrich Tews, David Stolz, Dominik Bergis, Thorsten Lenthe, Frank Schmidt‐Mergenthaler, Elke Dahlmann, Kathrin Boehm, Malte Jacobsen, Dirk Müller‐Wieland, Julia Brandts   +21 more
wiley   +1 more source

In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies. [PDF]

In Silico Pharmacol, 2017
Sharma MC, Jain S, Sharma R.
europepmc   +1 more source

Safety and Efficiency of Dipeptidyl Peptidase IV Inhibitors in Patients with Diabetic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Curr Ther Res Clin Exp
Tuersun A, Mohetaer M, Hou G, Cheng G.
europepmc   +1 more source

Efficacy and Safety of the Utilization of Dipeptidyl Peptidase IV Inhibitors in Diabetic Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials. [PDF]

Diabetes Metab Syndr Obes
Mahzari MM, Alqirnas MQ, Alhamadh MS, Alrasheed F, Alhabeeb AY, Al Madani W, Aldera H.   +6 more
europepmc   +1 more source

In vitro screening for protein tyrosine phosphatase 1B and dipeptidyl peptidase IV inhibitors from selected Nigerian medicinal plants. [PDF]

J Intercult Ethnopharmacol, 2017
Saidu Y, Muhammad SA, Abbas AY, Onu A, Tsado IM, Muhammad L.   +5 more
europepmc   +1 more source

Sita‐ and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross‐sectional study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page e227-e230, April 2026.
Sören Dräger, Claudia Kauderer, Svenja Meyhöfer, Leonie Dräger, Jens U. Marquardt, Ralf J. Ludwig, Stephan Arndt, Katharina Boch, Katja Bieber   +8 more
wiley   +1 more source

Delayed post-operative bradykinin-mediated angioedema: A silent airway threat and role of tranexamic acid. [PDF]

Indian J Anaesth
Madoo N, Balavenkatasubramanian J, Gurumoorthi P.   +2 more
europepmc   +1 more source

Dipeptidyl Peptidase-4 Inhibitors Associated with Lower Psoriatic Disease Risk in Type 2 Diabetes: A 13-Year Nationwide Cohort Study with Mechanistic Validation. [PDF]

Acta Derm Venereol
Hung CT, Chung CH, Weng TH, Tsai CT, Chien WC, Chang YL.   +5 more
europepmc   +1 more source

Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature. [PDF]

J Dermatol Case Rep, 2014
Attaway A, Mersfelder TL, Vaishnav S, Baker JK.   +3 more
europepmc   +1 more source

Lobeglitazone and the risk of renal progression in Korean patients with type 2 diabetes mellitus: a retrospective cohort study. [PDF]

BMJ Open
Hong SH, Lee H, Lee SY, Sung YA, Hong YS, Song DK, Jung H, Kim MH.   +7 more
europepmc   +1 more source